Safety Study of Soluble Ferric Pyrophosphate (SFP) in Dialysate in CKD Patients Receiving Chronic Hemodialysis

NCT01503021 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

718

Enrollment

INDUSTRY

Sponsor class

Conditions

End Stage Renal Disease
Chronic Kidney Disease

Interventions

DRUG: SFP
OTHER: Placebo

Sponsor

Rockwell Medical Technologies, Inc.